financetom
Business
financetom
/
Business
/
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Aug 29, 2024 5:19 AM

04:14 PM EDT, 08/27/2024 (MT Newswires) -- James D Rine, President, on Aug. 23, sold 7,315 shares in Umb Financial ( UMBF ) for $735,162. Following the Form 4 filing with the SEC, Rine has control over a total of 46,339 shares of the company, with 44,917 shares held directly and 1,422 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/101382/000112760224022963/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Aug 29, 2024
08:08 AM EDT, 08/29/2024 (MT Newswires) -- Catalent ( CTLT ) reported fiscal Q4 adjusted earnings Thursday of $0.65 per diluted share, up from $0.02 a year earlier. Analysts polled by Capital IQ expected $0.56. Net revenue for the quarter ended June 30 was $1.3 billion, up from $1.06 billion a year earlier. Analysts polled by Capital IQ expected $1.24...
XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease
XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease
Aug 29, 2024
08:09 AM EDT, 08/29/2024 (MT Newswires) -- XORTX Therapeutics ( XRTX ) jumped 62% on Thursday in New York premarket trading after the company said that recent peer-reviewed, independent, published research shows genetic factors are linked to the over-expression of xanthine oxidase (XO) and play a role in several diseases, including kidney disease. The findings support the company's approach to...
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Aug 29, 2024
04:14 PM EDT, 08/27/2024 (MT Newswires) -- James D Rine, President, on Aug. 23, sold 7,315 shares in Umb Financial ( UMBF ) for $735,162. Following the Form 4 filing with the SEC, Rine has control over a total of 46,339 shares of the company, with 44,917 shares held directly and 1,422 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/101382/000112760224022963/xslF345X05/form4.xml ...
Kanzhun's Board Approves New $150 Million Share Repurchase Program
Kanzhun's Board Approves New $150 Million Share Repurchase Program
Aug 29, 2024
08:09 AM EDT, 08/29/2024 (MT Newswires) -- Kanzhun ( BZ ) said Thursday that the company's board of directors has authorized a new $150 million share repurchase program, starting Aug. 29 for 12 months. The new program will operate together with the existing $200 million share repurchase program that became effective on Mar. 20 for 12 months, the company said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved